News
-
30 September 2020
Treating arteriosclerosis and cardiac arrhythmia in a single operation
Thanks to a new method, patients of Maastricht UMC+ can be treated in one single operation for vascular disorders (arteriosclerosis) and heart arrhythmia. This is done by making just a couple of small incisions in the chest. The patient is spared a second operation and in addition, this form of...
-
4 September 2020
Early treatment of atrial fibrillation means fewer complications later
Early treatment of chronic arrhythmia reduces the risk of serious cardiovascular complications and death, unlike the current standard protocol of merely monitoring and managing symptoms. These are the conclusions that a team of international researchers will publish today in the prestigious New...
-
8 July 2020
Maastricht researchers awarded Heart Foundation grant
The Dutch Heart Foundation has awarded Maastricht UMC+ researchers Constance Baaten and Pieter Goossens a "Dekker grant" (Dekkerbeurs). These are individual research grants for talented scientists, named after a former Heart Foundation director. With the grant of over 265,000 and 465,000...
-
14 April 2020
Remote care using a smartphone to monitor heart rhythm
Patients with heart arrhythmia can be monitored remotely using an app and their own smartphone. Cardiologists at Maastricht UMC+ use this method to track the heart rhythm of patients and to advise them remotely. Remote monitoring means that patients can avoid coming to hospital for an ECG during...
-
13 January 2020
Research into mutual causes of heart failure and vascular dementia
Researchers at Maastricht UMC+ are receiving almost one and a half million euros in funding to study the possible mutual causes of vascular dementia and heart failure. The theory is that a reduction in the number of small blood vessels lies at the root of both disorders. The researchers hope to...
-
14 August 2019
Self-learning model to predict risk of coronary heart disease
Researchers at Maastricht UMC+ and Maastricht University are receiving nearly two million euros in funding from the Netherlands Organisation for Scientific Research (NWO) to develop a self-learning eHealth app to prevent coronary heart disease. The digital tool will use vast amounts of data, for...
-
1 April 2019
'Wait and see' method is effective in atrial fibrillation
When atrial fibrillation has recently been detected, it is just as effective to wait 48 hours as to apply acute cardioversion (with an electrical shock or intravenous drip with medication). This is because in nearly 70 per cent of cases, the heart rhythm recovers spontaneously. This is the...
